Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

Abstract

INHIBITORS of the human immunodeficiency virus type 1 (HIV-1) protease have entered clinical study as potential therapeutic agents for HIV-1 infection. The clinical efficacy of HIV-1 reverse transcriptase inhibitors has been limited by the emergence of resistant viral variants. Similarly, variants expressing resistance to protease inhibitors have been derived in cell culture1-10. We now report the characterization of resistant variants isolated from patients undergoing therapy with the protease inhibitor MK-639 (formerly designated L-735,524). Five of these variants, isolated from four patients, exhibited cross-resistance to all members of a panel of six structurally diverse protease inhibitors. This suggests that com-bination therapy with multiple protease inhibitors may not prevent loss of antiviral activity resulting from resistance selection. In addition, previous therapy with one compound may abrogate the benefit of subsequent treatment with a second inhibitor.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Chen, C. M. et al. J. Cell Biochem. 18D, 166 (1994).

    Google Scholar 

  2. 2

    El-Farrash, M. A. et al. J. Virol. 68, 233–239 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  3. 3

    Ho, D. D. et al. J. Virol. 68, 2016–2020 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. 4

    Jacobsen, H. et al. Virology 206, 527–534 (1995).

    CAS  Article  Google Scholar 

  5. 5

    Kempf, D. J. et al. J. Cell Biochem. 18D, 130 (1994).

    Google Scholar 

  6. 6

    Markowitz, M. et al. J. Virol. 69, 701–706 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. 7

    Otto, M. J. et al. Proc. natn. Acad. Sci. U.S.A. 90, 7543–7547 (1993).

    ADS  CAS  Article  Google Scholar 

  8. 8

    Singh, M. K. et al. J. Cell Biochem. 17E, 86 (1993).

    Google Scholar 

  9. 9

    Tisdale, M. et al. Abstr. Third Int. Workshop HIV Drug Resistance, August 2–5, 1994, Kauai, Hawaii 14 (1994).

  10. 10

    Winslow, D. L. et al. AIDS 8, 753–756 (1994).

    CAS  Article  Google Scholar 

  11. 11

    Dorsey, B. D. et al. J. med. Chem. 37, 3443–3451 (1994).

    CAS  Article  Google Scholar 

  12. 12

    Vacca, J. P. et al. Proc. natn. Acad. Sci. U.S.A. 91, 4096–4100 (1994).

    ADS  CAS  Article  Google Scholar 

  13. 13

    Lam, P. et al. Science 263, 380–384 (1994).

    ADS  CAS  Article  Google Scholar 

  14. 14

    Otto, M. J. et al. Antimicrob. Agents Chemother. 37, 2606–2611 (1993).

    CAS  Article  Google Scholar 

  15. 15

    Kempf, D. J., Norbeck, D. W., Marsh, K. C. & Erickson, J. Abstr. Am. chem. Soc. 206, 119 (1993).

    Google Scholar 

  16. 16

    Craig, J. C. et al. Antivir. Res. 16, 295–305 (1991).

    CAS  Article  Google Scholar 

  17. 17

    Tung, R. D. et al. Tenth Int. Conf. AIDS 33 (1994).

  18. 18

    Getman, D. P. et al. J. med. Chem. 36, 288–291 (1993).

    CAS  Article  Google Scholar 

  19. 19

    Myers, G., Wain-Hobson, S., Korber, B., Smith, R. F. & Pavlakis, G. N. Human Retroviruses and AIDS (Los Alamos National Laboratory, Los Alamos, New Mexico, 1993).

    Google Scholar 

  20. 20

    Navia, M. A. et al. Nature 337, 615–620 (1989).

    ADS  CAS  Article  Google Scholar 

  21. 21

    Wlodawer, A. et al. Science 245, 616–621 (1989).

    ADS  CAS  Article  Google Scholar 

  22. 22

    Saag, M. S. et al. New Engl. J. Med. 329, 1065–1072 (1993).

    CAS  Article  Google Scholar 

  23. 23

    Chomczynski, P. & Sacchi, N. Analyt. Biochem. 162, 156–159 (1987).

    CAS  Article  Google Scholar 

  24. 24

    Colonno, R. J. et al. Proc. natn. Acad. Sci. U.S.A. 85, 5449–5453 (1988).

    ADS  CAS  Article  Google Scholar 

  25. 25

    Kohl, N. E. et al. Proc. natn. Acad. Sci. U.S.A. 85, 4686–4690 (1988).

    ADS  CAS  Article  Google Scholar 

  26. 26

    Adachi, A. et al. J. Virol. 59, 284–291 (1986).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. 27

    Byrnes, V. W. et al. Antimicrob. Agents Chemother. 37, 1576–1579 (1993).

    CAS  Article  Google Scholar 

  28. 28

    Nunberg, J. H. et al. J. Virol. 65, 4887–4892 (1991).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Condra, J., Schleif, W., Blahy, O. et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374, 569–571 (1995). https://doi.org/10.1038/374569a0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing